Literature DB >> 11386852

Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?

S G Heil1, N M Van der Put, E T Waas, M den Heijer, F J Trijbels, H J Blom.   

Abstract

Neural tube defects (NTD) arise in the first weeks of pregnancy due to a combination of environmental and genetic factors. In mothers of children with NTD elevated homocysteine (Hcy) levels and decreased plasma folate levels were observed, which suggests a defect in the folate-dependent Hcy metabolism. Therefore, mutations in genes coding for enzymes of this metabolism could be involved in NTD. Serine hydroxymethyltransferase (SHMT) catalyzes the reversible reaction of serine and tetrahydrofolate (THF) to glycine and 5,10-methylene THF. Two different isoforms of SHMT are known, one is present in the cytosol (cSHMT) and the other in the mitochondrion (mSHMT). Theoretically, mutated SHMT could lead to elevated Hcy levels and to an altered distribution of the different folate derivatives and might therefore become a risk factor for NTD. This study concerns the molecular genetic analysis of genes coding for both isoforms of the SHMT enzyme by single-stranded conformation polymorphism analysis. Several mutations as well as polymorphisms were found in both genes. The relevance of two variations, the 1420 C>T mutation of the cytosolic isoform and the 4-bp deletion of the mitochondrial isoform (delTCTT 1721-1724), to NTD risk was tested in a study group, which consisted of 109 NTD patients, 120 mothers of children with NTD, and 420 controls. Neither of the two polymorphisms led to an increased risk of NTD. In mothers with the 1420 CC genotype, significant increased Hcy levels are present. Also, significantly decreased red blood cell folate and plasma folate levels were present in individuals with the 1420 CC genotype. Probably, the 1420 C>T polymorphism causes a shift in distribution of the different folate derivatives. The 4-bp deletion of the mSHMT gene did not lead to altered Hcy or folate levels. So far, the results of this study provide no direct evidence for a role of defective SHMT functioning in NTD. Still, the influence of the 1420 C>T polymorphism of the cSHMT gene on the folate-related risk of NTD needs further investigation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386852     DOI: 10.1006/mgme.2001.3175

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  45 in total

Review 1.  Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?

Authors:  Vasco C Romão; Aurea Lima; Miguel Bernardes; Helena Canhão; João Eurico Fonseca
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population.

Authors:  C L Relton; C S Wilding; M S Pearce; A J Laffling; P A Jonas; S A Lynch; E J Tawn; J Burn
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

3.  Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent.

Authors:  Rita de Cássia Carvalho Barbosa; Débora Costa Menezes; Thiago Fernando Vasconcelos Freire; Diogo Campos Sales; Victor Hugo Medeiros Alencar; Silvia Helena Barem Rabenhorst
Journal:  Mol Biol Rep       Date:  2011-12-02       Impact factor: 2.316

4.  Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.

Authors:  J L K Van Hove; K Vande Kerckhove; J B Hennermann; V Mahieu; P Declercq; S Mertens; M De Becker; P S Kishnani; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 5.  Genetic markers of treatment response in rheumatoid arthritis.

Authors:  Joanna Wesoly; Judith A M Wessels; Henk-Jan Guchelaar; Tom W J Huizinga
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 6.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

Review 7.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

8.  Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk.

Authors:  Susan E Steck; Temitope Keku; Lesley M Butler; Joseph Galanko; Beri Massa; Robert C Millikan; Robert S Sandler
Journal:  J Nutrigenet Nutrigenomics       Date:  2008-06-02

9.  DHFR 19-bp deletion and SHMT C1420T polymorphisms and metabolite concentrations of the folate pathway in individuals with Down syndrome.

Authors:  Cristiani Cortez Mendes; Aline Maria Zanchetta de Aquino Raimundo; Luciana Dutra Oliveira; Bruna Lancia Zampieri; Gustavo Henrique Marucci; Joice Matos Biselli; Eny Maria Goloni-Bertollo; Marcos Nogueira Eberlin; Renato Haddad; Maria Francesca Riccio; Hélio Vannucchi; Valdemir Melechco Carvalho; Érika Cristina Pavarino
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-19

10.  Maternal and infant gene-folate interactions and the risk of neural tube defects.

Authors:  Analee J Etheredge; Richard H Finnell; Suzan L Carmichael; Edward J Lammer; Huiping Zhu; Laura E Mitchell; Gary M Shaw
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.